Aaron Fletcher
Director/Board Member presso COGNITION THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Aaron G.
L.
Fletcher is the founder of Bios Research LLC, founded in 2012, where he holds the title of President.
He is also the founder of BIOS Capital Management LP, founded in 2014, where he holds the title of Managing Partner.
Currently, Dr. Fletcher is the Chairman at Actuate Therapeutics, Inc. He is also a Director at Lung Therapeutics, Inc. since 2014, an Independent Director at Cognition Therapeutics, Inc. since 2015, and a Director at Abilitech Medical, Inc. since 2017.
In the past, Dr. Fletcher served as the Chairman of TFF Pharmaceuticals, Inc. from 2018 to 2023.
He was also an Independent Director at SWK Holdings Corp.
from 2019 to 2021, and at Cue Biopharma, Inc. from 2019 to 2023.
Additionally, he worked as a Professor at Dallas Baptist University.
Dr. Fletcher obtained his doctorate degree from Colorado State University in 2007 and completed his undergraduate studies at York College.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
CUE BIOPHARMA, INC.
2.47% | 12/04/2023 | 1 113 867 ( 2.47% ) | 2 M $ | 31/03/2024 |
AZITRA INC
0.56% | 21/06/2023 | 162 020 ( 0.56% ) | 33 376 $ | 31/03/2024 |
08/11/2023 | 6 000 ( 0.02% ) | 10 920 $ | 31/03/2024 |
Posizioni attive di Aaron Fletcher
Società | Posizione | Inizio |
---|---|---|
COGNITION THERAPEUTICS, INC. | Director/Board Member | 01/01/2015 |
Lung Therapeutics, Inc.
Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Director/Board Member | 01/01/2014 |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. operates as a private biopharmaceutical company. It offers treatment for cancer and inflammatory diseases. The company was founded by Andrew P. Mazar in 2015 and is headquartered in Fort Worth, TX. | Chairman | - |
Abilitech Medical, Inc.
Abilitech Medical, Inc. Medical/Nursing ServicesHealth Services Abilitech Medical, Inc. provides solution to restore function and independence to those affected by neuromuscular conditions. Its product portfolio include Abilitech Assist, Abilitech Medical AbiliGrip, and AbiliGrasp Robotic Assist. The company was founded by Angie Zavoral Conley in 2016 and is headquartered in Eden Prairie, MN. | Director/Board Member | 01/01/2017 |
Bios Research LLC
Bios Research LLC Investment ManagersFinance Part of BIOS Capital Management LP, Bios Research LLC is a private company that provides investment advice. The company is based in Austin, TX. The company was founded by Aaron G. L. Fletcher. | Founder | 01/01/2012 |
BIOS Capital Management LP
BIOS Capital Management LP Investment ManagersFinance BIOS Capital Management LP (BIOS Partners) is a venture capital firm founded in 2014 by Stella Robertson, Aaron Fletcher and Leslie Kreis. The firm is headquartered in Fort Worth, Texas. | Founder | 01/01/2014 |
Precedenti posizioni note di Aaron Fletcher
Società | Posizione | Fine |
---|---|---|
TFF PHARMACEUTICALS, INC. | Chairman | 21/11/2023 |
CUE BIOPHARMA, INC. | Director/Board Member | 09/10/2023 |
SWK HOLDINGS CORPORATION | Director/Board Member | 31/12/2021 |
░░░░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Aaron Fletcher
Colorado State University | Doctorate Degree |
York College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
COGNITION THERAPEUTICS, INC. | Health Technology |
SWK HOLDINGS CORPORATION | Finance |
CUE BIOPHARMA, INC. | Health Technology |
TFF PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Lung Therapeutics, Inc.
Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Health Technology |
Bios Research LLC
Bios Research LLC Investment ManagersFinance Part of BIOS Capital Management LP, Bios Research LLC is a private company that provides investment advice. The company is based in Austin, TX. The company was founded by Aaron G. L. Fletcher. | Finance |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. operates as a private biopharmaceutical company. It offers treatment for cancer and inflammatory diseases. The company was founded by Andrew P. Mazar in 2015 and is headquartered in Fort Worth, TX. | Health Technology |
BIOS Capital Management LP
BIOS Capital Management LP Investment ManagersFinance BIOS Capital Management LP (BIOS Partners) is a venture capital firm founded in 2014 by Stella Robertson, Aaron Fletcher and Leslie Kreis. The firm is headquartered in Fort Worth, Texas. | Finance |
Abilitech Medical, Inc.
Abilitech Medical, Inc. Medical/Nursing ServicesHealth Services Abilitech Medical, Inc. provides solution to restore function and independence to those affected by neuromuscular conditions. Its product portfolio include Abilitech Assist, Abilitech Medical AbiliGrip, and AbiliGrasp Robotic Assist. The company was founded by Angie Zavoral Conley in 2016 and is headquartered in Eden Prairie, MN. | Health Services |
- Borsa valori
- Insiders
- Aaron Fletcher